As part of the Icahn Institute and Department of Genetics and Genomic Sciences, we provide a number of technical resources to our clinicians and scientists. We’ve invested in state-of-the-art software and computing systems, all of which are available within the School and the Mount Sinai Health System.


The Icahn School of Medicine at Mount Sinai is proud to introduce Minerva, a supercomputer dedicated to improving scientific discovery. Minerva is named after the Roman goddess of wisdom and medicine. Minerva consists of 7,680 AMD compute cores, 30,000 gigabytes of memory, and 1,500,000 gigabytes of high speed parallel storage. It has a peak speed of 70,000 gigaflops, and will provide 64 million hours of computation per year.


Our BioMe Biobank platform is an ongoing, prospective, hospital-based population research study that has enrolled over 25,000 participants and currently enrolls, on average, 600 new participants per month. Today, BioMe is a prototype example of an EMR-linked Biobank that integrates a patient’s clinical care information and research data.

You can learn more about our program in the National Research Council’s report 'Towards Precision Medicine.'


One of the major goals of systems biology is to understand how genetic and environmental variations drive transcriptional networks, protein-protein interaction networks, metabolite networks, and give arise to complex phenotypes.

We developed a computational framework centered around Bayesian network and implemented it in RIMBANet, which you can download for free here.

We have used RIMBANet to discover causal relationships in complex human diseases such as diabetes and obesity. We’ve also  applied RIMBANet to investigate how genetic variations regulate transcriptional and metabolite level changes in yeast.

For questions related to the RIMBANet package or the yeast data set, please contact Jun Zhu, PhD or Eric Schadt, PhD.


REVEL (Rare Exome Variant Ensemble Learner) is an ensemble method for predicting the pathogenicity of missense variants in the human genome by combining 18 individual functional prediction and conservation scores. REVEL performs significantly better than existing tools, especially for rare variants. REVEL scores for all human missense variants are available at: